{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:24:20Z","timestamp":1789953860024,"version":"4.0.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1093\/neuonc\/nou310","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T01:16:23Z","timestamp":1415927783000},"page":"822-831","source":"Crossref","is-referenced-by-count":15,"title":["Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy"],"prefix":"10.1093","volume":"17","author":[{"given":"Yibing","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kovalchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthi","family":"Jayanthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Lun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kovalchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James R.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kirton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aru","family":"Narendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"issue":"(5 Pt 1)","key":"key\n\t\t\t\t20170522211042_NOU310C1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0190-9622(91)70115-I","article-title":"Neurocutaneous melanosis: definition and review of the literature","volume":"24","author":"Kadonaga","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"(3)","key":"key\n\t\t\t\t20170522211042_NOU310C2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.sder.2010.06.007","article-title":"The risk of melanoma and neurocutaneous melanosis associated with congenital melanocytic nevi","volume":"29","author":"Shah","year":"2010","journal-title":"Semin Cutan Med Surg"},{"issue":"(6)","key":"key\n\t\t\t\t20170522211042_NOU310C3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jaad.2005.07.046","article-title":"Asymptomatic neurocutaneous melanocytosis in patients with large congenital melanocytic nevi: a study of cases from an Internet-based registry","volume":"53","author":"Agero","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"(1 Suppl)","key":"key\n\t\t\t\t20170522211042_NOU310C4","doi-asserted-by":"crossref","first-page":"1e","DOI":"10.1097\/PRS.0b013e3181ab11be","article-title":"Giant congenital melanocytic nevi","volume":"124","author":"Arneja","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"(3)","key":"key\n\t\t\t\t20170522211042_NOU310C5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/15513818809042969","article-title":"The melanocytic differentiation pathway in congenital melanocytic nevi: theoretical considerations","volume":"8","author":"Cramer","year":"1988","journal-title":"Pediatr Pathol"},{"issue":"(9)","key":"key\n\t\t\t\t20170522211042_NOU310C6","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/jid.2013.70","article-title":"Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS","volume":"133","author":"Kinsler","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"(3)","key":"key\n\t\t\t\t20170522211042_NOU310C7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1523-1747.ep12371783","article-title":"Ras mutations in human melanoma: a marker of malignant progression","volume":"102","author":"Ball","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"(4)","key":"key\n\t\t\t\t20170522211042_NOU310C8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/jid.2013.429","article-title":"NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi","volume":"134","author":"Charbel","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"(2)","key":"key\n\t\t\t\t20170522211042_NOU310C9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0344-0338(11)80709-0","article-title":"Establishment and characterization of a malignant melanoma cell line (YP-MEL) derived from a patient with neurocutaneous melanosis","volume":"190","author":"Nagashima","year":"1994","journal-title":"Pathol Res Pract"},{"issue":"(1)","key":"key\n\t\t\t\t20170522211042_NOU310C10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"issue":"(3)","key":"key\n\t\t\t\t20170522211042_NOU310C11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molonc.2013.01.001","article-title":"Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting","volume":"7","author":"Singh","year":"2013","journal-title":"Mol Oncol"},{"issue":"(2)","key":"key\n\t\t\t\t20170522211042_NOU310C12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"issue":"(12)","key":"key\n\t\t\t\t20170522211042_NOU310C13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.18632\/oncotarget.785","article-title":"Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway","volume":"3","author":"Alajez","year":"2012","journal-title":"Oncotarget"},{"issue":"(9)","key":"key\n\t\t\t\t20170522211042_NOU310C14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1101\/gad.415007","article-title":"Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency","volume":"21","author":"Polesskaya","year":"2007","journal-title":"Genes Dev"},{"issue":"(4)","key":"key\n\t\t\t\t20170522211042_NOU310C15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/2159-8290.CD-12-0464","article-title":"Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes","volume":"3","author":"Pedersen","year":"2013","journal-title":"Cancer Discov"},{"key":"key\n\t\t\t\t20170522211042_NOU310C16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2051-5960-2-41","article-title":"Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor","volume":"2","author":"Kusters-Vandevelde","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"(4)","key":"key\n\t\t\t\t20170522211042_NOU310C17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/CMR.0b013e328343a1d6","article-title":"Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R","volume":"21","author":"Molhoek","year":"2011","journal-title":"Melanoma Res"},{"issue":"(6)","key":"key\n\t\t\t\t20170522211042_NOU310C18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/sj.jid.5701185","article-title":"IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin","volume":"128","author":"Hilmi","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"(1)","key":"key\n\t\t\t\t20170522211042_NOU310C19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0014-4827(03)00049-1","article-title":"Insulin-like growth factor I-stimulated melanoma cell migration requires phosphoinositide 3-kinase but not extracellular-regulated kinase activation","volume":"286","author":"Neudauer","year":"2003","journal-title":"Exp Cell Res"},{"issue":"(1)","key":"key\n\t\t\t\t20170522211042_NOU310C20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J","article-title":"Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis","volume":"183","author":"Grimberg","year":"2000","journal-title":"J Cell Physiol"},{"issue":"(5)","key":"key\n\t\t\t\t20170522211042_NOU310C21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00018-007-7486-z","article-title":"Thrombospondins in cancer","volume":"65","author":"Kazerounian","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"(2)","key":"key\n\t\t\t\t20170522211042_NOU310C22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.matbio.2012.11.010","article-title":"Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis","volume":"32","author":"Lindner","year":"2013","journal-title":"Matrix Biol"},{"issue":"(1)","key":"key\n\t\t\t\t20170522211042_NOU310C23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2010.10.027","article-title":"Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells","volume":"301","author":"Satelli","year":"2011","journal-title":"Cancer Lett"},{"issue":"(3)","key":"key\n\t\t\t\t20170522211042_NOU310C24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng904","article-title":"Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer","volume":"31","author":"Anand","year":"2002","journal-title":"Nat Genet"},{"issue":"(3)","key":"key\n\t\t\t\t20170522211042_NOU310C25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2133.2007.08390.x","article-title":"Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines","volume":"158","author":"Sorolla","year":"2008","journal-title":"Br J Dermatol"},{"issue":"(3)","key":"key\n\t\t\t\t20170522211042_NOU310C26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12094-010-0486-8","article-title":"Heat shock proteins as targets in oncology","volume":"12","author":"Gim\u00e9nez Ortiz","year":"2010","journal-title":"Clin Transl Oncol"},{"issue":"(2)","key":"key\n\t\t\t\t20170522211042_NOU310C27","doi-asserted-by":"crossref","first-page":"e56134","DOI":"10.1371\/journal.pone.0056134","article-title":"Activity of the heat shock protein 90 inhibitor ganetespib in melanoma","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/17\/6\/822\/17430275\/nou310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T19:18:01Z","timestamp":1598469481000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nou310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,11,12]]},"published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nou310","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}